Archived TB Guidelines

Archived TB Guidelines MMWR
Title	Format	Date Published
Notice to Readers: Updated Guidelines on Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis MMWR 2008; 57 (No. 4, 98)	PDF (268 KB)	01/2008
Errata: Treatment of Tuberculosis MMWR 2005; 52 (RR–11)	N/A	1/2005
Treating Opportunistic Infections Among HIV–Infected Adults and Adolescents MMWR 2004; 53 (RR15)	N/A	12/2004
Treating Opportunistic Infections Among HIV–Exposed and Infected Children MMWR 2004; 53 (RR14)	N/A	12/2004
Notice to Readers: Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV–Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors MMWR 2004; 53 (No. 2)		1/2004
Treatment of Tuberculosis MMWR 2003; 52 (No. RR–11) : Errata :TB Treatment Guidelines in PDA Format	N/A	6/2003
Guidelines for Using the QuantiFERON®–TB Test for Diagnosing Latent Mycobacterium tuberculosis Infection MMWR 2002; 51 (12/18/02)	PDF (398 KB)	1/2003
Public Health Dispatch: Update: Fatal and Severe Liver Injuries Associated with Rifampin and Pyrazinamide Treatment for Latent Tuberculosis Infection MMWR 2002; 51 (No. 44)		11/2002
Guidelines for Preventing Opportunistic Infections Among HIV–Infected Persons — 2002 MMWR 2002; 51 (No. RR–8)	N/A	6/2002
Preventing and Controlling Tuberculosis Along the U.S.–Mexico Border Work Group Report MMWR 2001; 50 (No. RR–1)	N/A	1/2001
Update: Nucleic Acid Amplification Tests for Tuberculosis MMWR 2000; 49 (No. 26)	N/A	7/2000
Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors MMWR 2000: 49 (No. 9)	N/A	3/2000
Diagnostic Standards and Classification of Tuberculosis in Adults and Children Am J Respir Crit Care Med 2000; 161	PDF 168 KB)	7/1999
Prevention and Treatment of Tuberculosis among Patients Infected with Human Immunodeficiency Virus: Principles of Therapy and Revised Recommendations MMWR 1998; 47 (No. RR–20)	PDF (743 KB)	10/1998
Anergy Skin Testing and Preventive Therapy for HIV–Infected Persons: Revised Recommendations MMWR 1997; 46 (No. RR–15)	PDF (1.8 MB)	9/1997
Nucleic Acid Amplification Tests for Tuberculosis MMWR 1996; 45 (No. 43)	N/A	11/1996
Prevention and Control of Tuberculosis in Correctional Facilities (ACET) MMWR 1996; 45 (No. RR–8)	N/A	6/1996
Essential Components of a Tuberculosis Prevention and Control Program (ACET) MMWR 1995; 44 (No. RR-11)	PDF [357 KB]	9/1995
Screening for Tuberculosis and Tuberculosis Infection in High–Risk Populations (ACET) MMWR 1995; 44 (No. RR–11)	PDF (358 KB)	9/1995
Guidelines for Preventing the transmission of Mycobacterium tuberculosis in Health–Care Facilities, 1994 MMWR 1994; 43 (No. RR–13)	PDF (8.5 MB)	10/1994
Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of Vaccines and Immune Globulins in Persons with Altered Immunocompetence MMWR 1993; 42 (No. RR-4)	N/A	4/1993
Prevention and Control of Tuberculosis in Migrant Farm Workers (ACET) MMWR 1992; 41 (No. RR–10)	N/A	6/1992
National Action Plan to Combat Multidrug–Resistant Tuberculosis MMWR 1992; 41 (RR–11)	N/A	6/1992
Management of Persons Exposed to Multidrug–Resistant Tuberculosis MMWR 1992; 41 (RR–11)	N/A	6/1992
Prevention and Control of Tuberculosis in U.S. Communities with At–Risk Minority Populations (ACET) MMWR 1992; 41 (No. RR–5)	N/A	4/1992
Prevention and Control of Tuberculosis Among Homeless Persons (ACET) MMWR 1992; 41 (No. RR–5)	N/A	4/1992
Prevention and Control of Tuberculosis in Facilities Providing Long–Term Care to the Elderly (ACET) MMWR 1990; 39 (RR–10)	N/A	7/1990
A Strategic Plan for the Elimination of Tuberculosis in the United States MMWR 1989; 38 (S–3).	N/A	4/1989